Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
The Cherokee Nation v. Takeda Pharmaceuticals U S A Inc et al
Case Number:
6:15-cv-01485
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
August 24, 2017
Cherokee Nation Wants Takeda Actos Suit To Stay In La.
The Cherokee Nation told a Louisiana magistrate judge Thursday that a request by Takeda Pharmaceutical Co. Ltd. to transfer the tribe’s suit to Oklahoma would hurt the tribe’s ability to recover medical costs connected with treatment it provided for injuries related to the company’s diabetes drug Actos.
-
May 11, 2015
Cherokee Suit Against Takeda Transferred To Actos MDL
A Louisiana magistrate judge on Monday transferred the Cherokee Nation's proposed class action against Takeda Pharmaceutical Co. Ltd. over distribution of a $2.4 billion settlement, set to go to users of its diabetes drug Actos, into multidistrict litigation that encompasses overarching claims against the company.
-
April 30, 2015
Cherokees Seek Share Of $2.4B Actos Deal On Behalf Of Tribes
The Cherokee Nation hit Takeda Pharmaceutical Co. Ltd. with a proposed class action in Louisiana federal court Thursday, saying the company can't distribute a $2.4 billion settlement over alleged health risks associated with the diabetes drug Actos until it determines how much to pay tribes for covering members' health care costs.